Obstruction-Free Survival Following Operative Intervention for Malignant Bowel Obstruction in Appendiceal Cancer
Patients with peritoneal metastases from appendiceal cancer are at high risk of malignant bowel obstruction (MBO), which is associated with significant morbidity and mortality. There are no definitive treatment guidelines regarding operative intervention for MBO. We sought to evaluate the efficacy and safety of operative intervention in this population.
We identified patients with peritoneal metastases from appendiceal cancer who underwent surgery for MBO at our institution between 2011 and 2018. Baseline characteristics, postoperative complications, and follow-up data were collected. The primary endpoint was obstruction-free survival (OFS). Other endpoints were postoperative recovery of bowel function, 60-day Clavien–Dindo (CD) morbidity, and overall survival (OS).
Twenty-six patients underwent operative treatment for MBO, of whom 14 had high-grade (HG) histology and 12 had low-grade (LG) histology. Seven (25.9%) patients had severe (CD grade 3 or higher) 60-day complications, including one (3.8%) postoperative death. All remaining patients had return of bowel function and resumed oral intake during hospitalization. Six (23.1%) patients had repeat admissions for MBO after surgery. Median OFS was 17.0 months (95% confidence interval [CI] 2.3–31.8), and median OS was 18.5 months (95% CI 3.6–33.3) following surgery.
In this carefully selected group of patients with peritoneal metastases from appendiceal cancer, surgery for MBO provided durable palliation with acceptable morbidity.
This study was supported by a University of California San Diego Clinical and Translational Research Institute Grant (UL1TR001442).
Joel M. Baumgartner, Rebecca Marmor, Athena Hsu, Jula Veerapong, Kaitlyn J. Kelly, and Andrew M. Lowy have no disclosures or relevant conflicts of interest to declare.
- 2.Feuer DJ, Broadley KE, Shepherd JH, Barton DP. Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev. 2000;(4):CD002764.Google Scholar
- 4.Wong TH, Tan YM. Surgery for the palliation of intestinal obstruction in advanced abdominal malignancy. Singap Med J. 2009;50(12):1139–1144.Google Scholar
- 5.Henry JC, Pouly S, Sullivan R, et al. A scoring system for the prognosis and treatment of malignant bowel obstruction. Surgery. 2012;152(4):747–756; discussion 756–747.Google Scholar
- 13.Santangelo ML, Grifasi C, Criscitiello C, et al. Bowel obstruction and peritoneal carcinomatosis in the elderly. A systematic review. Aging Clin Exp Res. 2017;29 Suppl 1:73–78.Google Scholar
- 15.Ihemelandu C, Fernandez S, Sugarbaker PH. A prognostic model for predicting overall survival in patients with peritoneal surface malignancy of an appendiceal origin treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2017;24(8):2266–2272.CrossRefPubMedGoogle Scholar
- 16.World Health Organization Classification of Tumours of the Digestive Tract. Vol 3. 4th ed. Lyon: IARC Press; 2010Google Scholar
- 17.Carr NJ, Cecil TD, Mohamed F, et al. A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal Neoplasia: the results of the Peritoneal Surface Oncology Group International (PSOGI) modified delphi process. Am J Surg Pathol. 2016;40(1):14–26.CrossRefGoogle Scholar
- 21.SWOG. SWOG Study S1316. Prospective comparative effectiveness trial for malignant bowel obstruction. 2017. Available at: http://swog.org/Visitors/S1316/.